About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 438 record(s)
Req # A-2020-000066
Adverse Reaction Report (AER) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: E2B_02564415, E2B_02564522, E2B_02567164, E2B_02564513, E2B_02567215, E2B_02564869, E2B_02565020, E2B_02564929, E2B_025648+C29:C3363, E2B_02565199, E2B_02564584, E2B_02565208, E2B_02564583, E2B_02567072, E2B_02564554, E2B_02565143, E2B_02567085, E2B_02564535, E2B_02567087, E2B_02610152.Organization: Health Canada
July 2020
Req # A-2020-000070
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02655367, E2B_02564318, E2B_02590882, E2B_02542374, E2B_02546157, E2B_02549592, E2B_02549861, E2B_02561169, E2B_02561355, E2B_02589105, 000724948, E2B_02494146, E2B_02496560, 000727575, E2B_02495950, 000727310, E2B_02493939, E2B_02526409, E2B_02598262, E2B_02600159.Organization: Health Canada
July 2020
Req # A-2020-000071
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02606418, E2B_02608012, E2B_02607127, E2B_02613556, E2B_02578626, E2B_02585269, E2B_02642108, E2 B_02643457, E2B_02643564, E2B_02645077, E2B_01361047, E2B_00778650, E2B_02646748, E2B_02647498, E2B_00481009, E2B_00495172, E2B_00481009, E2B_00481009, 000724367, E2B_02562487.Organization: Health Canada
July 2020
Req # A-2020-000076
Adverse Reaction Report (AER) for INSULIN GLARGINE. Report numbers: 000725089, 000725777, 000726058, 000726283, E2B_02553743, E2B_02609446, E2B_02631995, 000724670, 725090, E2B_02551031.Organization: Health Canada
July 2020
Req # A-2020-000102
Adverse Reaction Report (AER). Report number: E2B_02983084.Organization: Health Canada
July 2020
Req # A-2020-000126
Adverse Reaction Report (AER). Report numbers: 000733571, 000733940, E2B_02866902, E2B_02866905.Organization: Health Canada
July 2020
Req # A-2020-000130
Adverse Reaction Report (AER). Report numbers: 000719523, 000719683, 000719639, 000719687, E2B_02155932, E2B_02158784, E2B_02162429, E2B_02181848, E2B_02191642, 000719746, E2B_02251476.Organization: Health Canada
July 2020
Req # A-2020-000136
Adverse Reaction Report (AER). Report numbers: E2B_02937202, E2B_02937350, E2B_02937259, E2B_02937361.Organization: Health Canada
July 2020
Req # A-2020-000150
Adverse Reaction Report (AER). Report numbers: E2B_02972734, E2B_02974799.Organization: Health Canada
July 2020
Req # A-2020-000153
Adverse Reaction Report (AER). Report numbers: E2B_02866495, E2B_02866496.Organization: Health Canada
July 2020